Federal regulations

The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.

FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.

The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.

FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.

I need the description to create an accurate summary. Please provide the description field for this OMB submission document.

Farm Service Agency seeks public comments on a revised information collection for General Program Administration to verify applicant eligibility, authorized loan use, and government security interests under the Paperwork Reduction Act.

OMB review process for federal regulations requires public comment submissions; the comment period deadline and specific regulatory details are not specified in the title alone.

Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.

Multiple federal agency forms are undergoing Paperwork Reduction Act review to assess and potentially reduce reporting burdens on small businesses and other respondents.

FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.